Patient Inclusion Criteria:  Age ≥ 65 Able to provide informed consent. All patients will be assessed using the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) 56 - a score >14.5 will define ability to independently provide informed consent. Eligible patients have Stage III or IV cancer of any type Additionally, at least 20 patients will have a will have a high likelihood of MCI based on screening score of <26 on the Montreal Cognitive Assessment (MoCA) within their eRecord chart. Able to read and understand English  Patient Exclusion Criteria:  Patients who do not have decision-making capacity (as determined by UBACC as described above) AND do NOT have a previously designated health care proxy (established prior to their cognitive impairment) available to sign consent. Unable to identify caregiver to participate in study.  Caregiver Inclusion Criteria:  One caregiver for each patient will be eligible and must be chosen by the patient. For the purposes of this study, a caregiver is defined as a valued and trusted person in a patient's life who is supportive in health care matters by providing valuable social support and/or direct assistive care. Caregivers will be selected by the patient when asked if there is a "family member, partner, friend or caregiver with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") will remain eligible for the study. Age 50 or older Ability to provide consent Proficient in English  Caregiver Exclusion Criteria  Caregivers unable to understand the consent form due to cognitive, health or sensory impairment will be excluded